4Q charges drive Bayer into loss
German chemical and pharmaceuticals group Bayer has said it expects to slip into the red in 2003.
German chemical and pharmaceuticals group Bayer has said it expects to slip into the red in 2003.
UK-headquartered separations company Whatman is to sell its filter cartridge business to Graver Technologies of the US for $2.1 million (€1.7m) in cash, continuing a string of divestments as it copes with a decline in revenues.
Switzerland's Lonza has won a long-term manufacturing contract from US biotechnology bellwether Genentech for Rituxan (rituximab) a biological drug which recorded worldwide sales of $1.48 billion in 2002.